Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.
about
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.Targeting the dopamine D3 receptor: an overview of drug design strategies.Pramipexole derivatives as potent and selective dopamine D(3) receptor agonists with improved human microsomal stability.Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity.High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice.Inhibitors of Protein Methyltransferases and Demethylases.Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors.cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor.Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R).
P2860
Q28067056-6C59BFCC-333F-40AB-BDA1-AA1A86B4816EQ34524556-60E6213E-9880-4A18-91FD-7C805126B131Q34775660-5163C026-3EB1-420A-A40A-C1BE6314FBE4Q35554948-5D0B45CE-B659-48DA-A5C5-7DA6C934D2BAQ35892818-0FC00BF3-9A99-4AC1-A4DB-EB2E1C0DE958Q35962179-CAB15C13-4126-4694-9055-99580E57D180Q37025051-DB9D34BF-AC59-4EE6-9D53-0647B9095922Q37077658-0EDA2637-CAEB-49E9-AFB6-4A6FA5BA9B2CQ38740496-BC23BCEC-E825-40A9-A557-C70B96D63319Q39252003-B60BBB9E-B28D-454A-B37F-20A1AEC5120DQ40955120-499A7088-939C-4034-8DCA-3D3A6306B8B0Q46734392-C37A616B-2567-4C0F-B452-EB85BCE0A274Q48099692-0631998C-9B1F-4CD1-AA25-E08973DA40D4Q48145124-7E23B7C0-362F-4774-A6F7-F4AEBAC6F9C9Q48252285-20BD18B7-1DC7-4EE6-BE6B-48EAE2CC8923
P2860
Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@ast
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@en
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@nl
type
label
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@ast
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@en
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@nl
prefLabel
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@ast
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@en
Tranylcypromine substituted ci ...... amine D₃ receptor antagonists.
@nl
P2093
P2860
P356
P1476
Tranylcypromine substituted ci ...... pamine D₃ receptor antagonists
@en
P2093
Amy Hauck Newman
Beth Levant
Cheng Jiang
Jianyong Chen
P2860
P304
P356
10.1021/JM401798R
P407
P577
2014-06-03T00:00:00Z